{"id":"W2269092789","doi":"10.1016/j.msard.2016.02.001","title":"Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"TransCanada (Canada)","funders":"Biogen","keywords":"Medicine; Daclizumab; Multiple sclerosis; Disease; Ocrelizumab; Relapsing remitting; Physical therapy; Clinical trial; Internal medicine; Natalizumab; Dimethyl fumarate; Alemtuzumab; Intensive care medicine; Immunology; Rituximab; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004169617,0.001110535,0.002925324,0.0004098606,0.0004514709,0.001292533,0.0004762573,0.001166106,0.002494148],"category_scores_gemma":[0.006277177,0.0002626241,0.004220369,0.0007658372,0.0007272277,0.001028612,0.0007898968,0.0016704,0.00027222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006140317,"about_ca_system_score_gemma":0.0009086095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001348034,"about_ca_topic_score_gemma":0.00260136,"domain_scores_codex":[0.9974732,0.001607391,0.0002619934,0.0002068399,0.0002893331,0.0001613574],"domain_scores_gemma":[0.9940727,0.002987105,0.001811925,0.0003084065,0.000291445,0.0005284847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9039854,0.001725874,0.03690018,0.002195397,0.02595266,0.00007433016,0.000146597,0.0006660441,0.001327671,0.0002283396,0.001026772,0.02577068],"study_design_scores_gemma":[0.5617189,0.126808,0.2451562,0.0007454753,0.05681595,0.0003039132,0.000519192,0.001218414,0.001394279,0.0009520571,0.00422558,0.0001420522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850973,0.01094662,0.0002312596,0.0004855099,0.0001614409,0.0002731675,0.00137495,0.00001672958,0.001412937],"genre_scores_gemma":[0.9927249,0.003523667,0.0004118901,0.0004077529,0.0003409949,0.0004956599,0.001339957,0.000008918551,0.0007463158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004169617,"threshold_uncertainty_score":0.02205127,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08869802365204665,"score_gpt":0.3298301914704027,"score_spread":0.241132167818356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}